These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 19887380)
21. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048 [TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-like weak inducer of apoptosis is a mitogen for liver progenitor cells. Tirnitz-Parker JE; Viebahn CS; Jakubowski A; Klopcic BR; Olynyk JK; Yeoh GC; Knight B Hepatology; 2010 Jul; 52(1):291-302. PubMed ID: 20578156 [TBL] [Abstract][Full Text] [Related]
23. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis. Kawashima R; Kawamura YI; Oshio T; Son A; Yamazaki M; Hagiwara T; Okada T; Inagaki-Ohara K; Wu P; Szak S; Kawamura YJ; Konishi F; Miyake O; Yano H; Saito Y; Burkly LC; Dohi T Gastroenterology; 2011 Dec; 141(6):2119-2129.e8. PubMed ID: 21893119 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases. Yepes M; Winkles JA Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600 [TBL] [Abstract][Full Text] [Related]
31. TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage. Kaduka Y; Takeda K; Nakayama M; Kinoshita K; Yagita H; Okumura K Biochem Biophys Res Commun; 2005 Jun; 331(2):384-90. PubMed ID: 15850771 [TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor receptor 1 gene expression is required for cardiomyocyte proliferation and is repressed by Sp3. Seyed M; Dimario JX J Mol Cell Cardiol; 2008 Mar; 44(3):510-9. PubMed ID: 18275970 [TBL] [Abstract][Full Text] [Related]
33. Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei. Walsh S; Pontén A; Fleischmann BK; Jovinge S Cardiovasc Res; 2010 Jun; 86(3):365-73. PubMed ID: 20071355 [TBL] [Abstract][Full Text] [Related]
34. TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy. Novoyatleva T; Janssen W; Wietelmann A; Schermuly RT; Engel FB Cytokine; 2013 Oct; 64(1):43-5. PubMed ID: 23764551 [TBL] [Abstract][Full Text] [Related]
35. Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity. Chacón MR; Richart C; Gómez JM; Megía A; Vilarrasa N; Fernández-Real JM; García-España A; Miranda M; Masdevall C; Ricard W; Caubet E; Soler J; Vendrell J Cytokine; 2006 Feb; 33(3):129-37. PubMed ID: 16503147 [TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of the canine cytokine TWEAK (CD255) and its receptor, Fn14 (CD266). Zhang JX; Sang M; Zhao W; Ai HX; Shui Y; Li JF; Song R; Zhang SQ Vet Immunol Immunopathol; 2010 Sep; 137(1-2):172-5. PubMed ID: 20452679 [TBL] [Abstract][Full Text] [Related]
38. Suppression of proliferation and cardiomyocyte hypertrophy by CHAMP, a cardiac-specific RNA helicase. Liu ZP; Olson EN Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2043-8. PubMed ID: 11854500 [TBL] [Abstract][Full Text] [Related]
39. Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke. Inta I; Frauenknecht K; Dörr H; Kohlhof P; Rabsilber T; Auffarth GU; Burkly L; Mittelbronn M; Hahm K; Sommer C; Schwaninger M J Neurol Sci; 2008 Dec; 275(1-2):117-20. PubMed ID: 18793781 [TBL] [Abstract][Full Text] [Related]